Literature DB >> 28267452

Clinical Applications of Molecular Imaging in the Management of Prostate Cancer.

Michael A Gorin1, Steven P Rowe2, Samuel R Denmeade3.   

Abstract

At the heart of selecting an optimal management strategy for men with prostate cancer is accurately determining a given patient's clinical stage and extent of disease. Molecular imaging with PET using properly selected radiotracers offers the opportunity for improved contrast resolution over conventional imaging and thus increased sensativity for detecting sites of disease. In addition, molecular imaging provides the prospect of obtaining functional or biological information regarding a patient's cancer. To date, several PET radiotracers have been developed for prostate cancer imaging. This review summarizes the potential clinical applications of molecular imaging in the management of men with prostate cancer.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cancer staging; Molecular imaging; PET; Prostate cancer

Mesh：

Substances：

Year:  2017        PMID： 28267452     DOI： 10.1016/j.cpet.2016.11.001

Source DB:  PubMed          Journal:  PET Clin        ISSN： 1556-8598


  3 in total

1.  Prostate Specific Membrane Antigen Targeted 18F-DCFPyL Positron Emission Tomography/Computerized Tomography for the Preoperative Staging of High Risk Prostate Cancer: Results of a Prospective, Phase II, Single Center Study.

Authors:  Michael A Gorin; Steven P Rowe; Hiten D Patel; Igor Vidal; Margarita Mana-Ay; Mehrbod S Javadi; Lilja B Solnes; Ashley E Ross; Edward M Schaeffer; Trinity J Bivalacqua; Alan W Partin; Kenneth J Pienta; Zsolt Szabo; Angelo M De Marzo; Martin G Pomper; Mohamad E Allaf
Journal:  J Urol       Date:  2017-07-20       Impact factor: 7.450

Review 2.  Pearls and pitfalls in clinical interpretation of prostate-specific membrane antigen (PSMA)-targeted PET imaging.

Authors:  Sara Sheikhbahaei; Ali Afshar-Oromieh; Matthias Eiber; Lilja B Solnes; Mehrbod S Javadi; Ashley E Ross; Kenneth J Pienta; Mohamad E Allaf; Uwe Haberkorn; Martin G Pomper; Michael A Gorin; Steven P Rowe
Journal:  Eur J Nucl Med Mol Imaging       Date:  2017-08-01       Impact factor: 9.236

Review 3.  Clinical perspectives of PSMA PET/MRI for prostate cancer.

Authors:  Felipe de Galiza Barbosa; Marcelo Araújo Queiroz; Rafael Fernandes Nunes; José Flávio Gomes Marin; Carlos Alberto Buchpiguel; Giovanni Guido Cerri
Journal:  Clinics (Sao Paulo)       Date:  2018-09-21       Impact factor: 2.365
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.